Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option (Q36110001)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option |
scientific article |
Statements
1 reference
Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option (English)
1 reference
Amarnath Natarajan
1 reference
Ziyan Yuan Pessetto
1 reference
Ying Yan
1 reference
Tadayoshi Bessho
1 reference
6 May 2012
1 reference
1 reference
511-517
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference